מדינה: מלטה
שפה: אנגלית
מקור: Medicines Authority
MOXIFLOXACIN
Aurobindo Pharma (Malta) Limited Vault 14, Level 2, Valletta Waterfront, Floriana FRN 1913, Malta
J01MA14
MOXIFLOXACIN 400 mg
FILM-COATED TABLET
MOXIFLOXACIN 400 mg
POM
ANTIBACTERIALS FOR SYSTEMIC USE
Withdrawn
2013-07-22
Page 1 of 10 PACKAGE LEAFLET: INFORMATION FOR THE USER MOXIFLOXACIN AUROBINDO 400 MG FILM-COATED TABLETS Moxifloxacin READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. Do not re-use this medicine without medical prescription, even if you want to treat a similar illness. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. - WHAT IS IN THIS LEAFLET: 1. What Moxifloxacin Aurobindo is and what it is used for 2. What you need to know before you take Moxifloxacin Aurobindo 3. How to take Moxifloxacin Aurobindo 4. Possible side effects 5. How to store Moxifloxacin Aurobindo 6. Contents of the pack and other information 1. WHAT MOXIFLOXACIN AUROBINDO IS AND WHAT IT IS USED FOR Moxifloxacin Aurobindo contains moxifloxacin as the active ingredient which belongs to a group of antibiotics called fluoroquinolones. Moxifloxacin Aurobindo works by killing bacteria that cause infections. Moxifloxacin Aurobindo is used in patients of 18 years and older for treating the following bacterial infections when caused by bacteria against which moxifloxacin is active. Moxifloxacin Aurobindo should only be used to treat these infections when usual antibiotics cannot be used or have not worked: • Infection of the sinuses • sudden worsening of long term inflammation of the airways or inf קרא את המסמך השלם
Page 1 of 17 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Moxifloxacin Aurobindo 400 mg film-coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 436.32 mg of moxifloxacin hydrochloride, equivalent to 400 of moxifloxacin. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Film-coated tablet Dull Red coloured, modified capsule shaped film coated tablets debossed with ‘E 18’ on one side and plain on the other side. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Moxifloxacin 400 mg film-coated tablets are indicated for the treatment of the following bacterial infections in patients of 18 years and older caused by bacteria susceptible to moxifloxacin (see sections 4.4, 4.8 and 5.1). Moxifloxacin should be used only when it is considered inappropriate to use antibacterial agents that are commonly recommended for the initial treatment of these infections or when these have failed: - Acute bacterial sinusitis (adequately diagnosed) - Acute exacerbations of chronic bronchitis (adequately diagnosed) - Community acquired pneumonia, except severe cases - Mild to moderate pelvic inflammatory disease (i.e. infections of female upper genital tract, including salpingitis and endometritis), without an associated tubo-ovarian or pelvic abscess. Moxifloxacin 400 mg film-coated tablets are not recommended for use in monotherapy of mild to moderate pelvic inflammatory disease but should be given in combination with another appropriate antibacterial agent (e.g. a cephalosporin) due to increasing moxifloxacin resistance of _Neisseria _ _gonorrhoeae_ unless moxifloxacin-resistant _Neisseria gonorrhoeae_ can be excluded (see sections 4.4 and 5.1). Moxiflox קרא את המסמך השלם